The endrocrine control mechanisms team are looking for new ways to treat ER-positive and lobular breast cancers.

The cancer stem cell team are working to understand how cancer stem cells are involved in the growth, reccurence and survival of breast cancer.

Researchers at the university of Exeter want to hear from autistic people how they experience breast cancer diagnosis and treatment. This will allow us to understand the barriers they may face and improve their care.

The functional tumour immunology team are studying how the immune system is affected by breast cancer so that they can develop new targeted treatments for the disease.

Professor Kristijan Ramadan is investigating how triple negative breast cancer can become resistant to drugs called PARP inhibitors and what treatments we could use next.

Professor Nick Lakin and his PhD student want to find signs that breast cancer cells are becoming resistant to drugs called PARP inhibitors and find new weaknesses in tumours that don’t respond to these drugs.